Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Utilize your home equity as a powerful tool to eliminate debt. Explore options that can help you regain financial stability.
23,247 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Bitcoin stirred market drama as it neared 69,000, triggering massive short liquidations. Across ethereum solana short...
Prediction markets for Bitcoin show a cautious view, but there may be a stronger upside catalyst many are overlooking...
March 2026 sees renewed volatility in energy and metals markets, prompting traders to reevaluate their platforms. Thi...
GameStop outperforms other meme stocks in 2026, climbing as speculative bets and buyout chatter around Ryan Cohen fue...
Ready to build a durable, long-term growth portfolio? This piece highlights two compelling picks and concrete steps t...
A week of trouble tested Amazon's operations and investor nerves. This article breaks down two essential takeaways an...
A private luncheon for the largest holders of a Trump-themed memecoin is back at Mar-a-Lago, renewing headlines about...
A Melius analyst warns that Microsoft's Copilot leadership reshuffle may signal deeper misalignment between AI ambiti...
Solana Foundation rolled out an AI agent thesis at a major New York summit, arguing a platform shift could redraw Sol...
A landmark innovator, Ted Turner reshaped TV by launching CNN, expanding cable, and preserving Hollywood classics. Th...